Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T18:04:44.053Z.
Calculation as of: 2026-10-06T18:04:44.053Z.
Quote observation: 2026-10-06T17:54:52.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 75b78fb0f07f9e339fd4071160809690f580f97426e97a581df10cf86c1fdb4f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-08-13.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Park Dental Partners, Inc. Common Stock
Market Cap
$92.33M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$88.62M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$88.21M
EV/FCF Ratio
21.78x
TTM Avg
56.27x
3Y Avg
59.65x
5Y Avg
59.65x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Park Dental Partners, Inc. Common Stock (PARK) | $92.33M | N/A | N/A | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $91.46M | N/A | N/A | N/A | N/A |
| Rallybio Corporation (RLYB)vs › | $90.85M | N/A | 0.18x | 0.18x | 0.18x |
| Equillium, Inc. (EQ)vs › | $89.78M | N/A | 5.17x | 5.17x | 5.17x |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.33M | N/A | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $89.26M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $89.02M | 5.98x | 5.69x | 5.19x | 9.05x |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $88.62M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 21.78x | 56.27x | 59.65x | 59.65x |
| Korro Bio, Inc. (KRRO)vs › | $97.24M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
0.0x
FCF Yield
5381.70%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2026-08-13 | 0.05x |
| 2026-08-12 | 0.05x |
| 2026-08-11 | 0.05x |
| 2026-08-10 | 0.05x |
| 2026-08-07 | 0.05x |
| 2026-08-06 | 0.05x |
| 2026-08-05 | 0.05x |
| 2026-08-04 | 0.04x |
| 2026-08-03 | 0.04x |
| 2026-07-31 | 0.04x |
| 2026-07-30 | 0.04x |
| 2026-07-29 | 0.04x |
| 2026-07-28 | 0.04x |
| 2026-07-27 | 0.04x |
| 2026-07-24 | 0.04x |
| 2026-07-23 | 0.04x |
| 2026-07-22 | 0.04x |
| 2026-07-21 | 0.04x |
| 2026-07-20 | 0.04x |
| 2026-07-17 | 0.04x |
| 2026-07-16 | 0.04x |
| 2026-07-15 | 0.04x |
| 2026-07-14 | 0.05x |
| 2026-07-13 | 0.05x |
| 2026-07-10 | 0.05x |
| 2026-07-09 | 0.05x |
| 2026-07-08 | 0.05x |
| 2026-07-07 | 0.05x |
| 2026-07-06 | 0.05x |
| 2026-07-02 | 0.05x |
| 2026-07-01 | 0.05x |
| 2026-06-30 | 0.05x |
| 2026-06-29 | 0.05x |
| 2026-06-26 | 0.04x |
| 2026-06-25 | 0.04x |
| 2026-06-24 | 0.04x |
| 2026-06-23 | 0.04x |
| 2026-06-22 | 0.04x |
| 2026-06-18 | 0.04x |
| 2026-06-17 | 0.04x |
| 2026-06-16 | 0.04x |
| 2026-06-15 | 0.04x |
| 2026-06-12 | 0.04x |
| 2026-06-11 | 0.04x |
| 2026-06-10 | 0.04x |
| 2026-06-09 | 0.04x |
| 2026-06-08 | 0.04x |
| 2026-06-05 | 0.04x |
| 2026-06-04 | 0.04x |
| 2026-06-03 | 0.05x |
| 2026-06-02 | 0.05x |
| 2026-06-01 | 0.04x |
| 2026-05-29 | 0.04x |
| 2026-05-28 | 0.04x |
| 2026-05-27 | 0.04x |
| 2026-05-26 | 0.04x |
| 2026-05-22 | 0.04x |
| 2026-05-21 | 0.04x |
| 2026-05-20 | 0.04x |
| 2026-05-19 | 0.04x |
| 2026-05-18 | 0.04x |
| 2026-05-15 | 0.04x |
| 2026-03-25 | 9.03x |
| 2026-03-24 | 9.00x |
| 2026-03-23 | 9.27x |
| 2026-03-20 | 9.09x |
| 2026-03-19 | 8.86x |
| 2026-03-18 | 8.99x |
| 2026-03-17 | 9.33x |
| 2026-03-16 | 9.33x |
| 2026-03-13 | 9.27x |
| 2026-03-12 | 9.63x |
| 2026-03-11 | 9.63x |
| 2026-03-10 | 9.66x |
| 2026-03-09 | 9.81x |
| 2026-03-06 | 10.14x |
| 2026-03-05 | 9.87x |
| 2026-03-04 | 9.91x |
| 2026-03-03 | 9.97x |
| 2026-03-02 | 9.97x |
| 2026-02-27 | 9.89x |
| 2026-02-26 | 10.07x |
| 2026-02-25 | 10.36x |
| 2026-02-24 | 10.09x |
| 2026-02-23 | 9.84x |
| 2026-02-20 | 9.77x |
| 2026-02-19 | 9.80x |
| 2026-02-18 | 9.85x |
| 2026-02-17 | 9.99x |
| 2026-02-13 | 9.99x |
| 2026-02-12 | 9.74x |
| 2026-02-11 | 10.02x |
| 2026-02-10 | 9.93x |
| 2026-02-09 | 9.51x |
| 2026-02-06 | 9.37x |
| 2026-02-05 | 8.90x |
| 2026-02-04 | 8.71x |
| 2026-02-03 | 8.70x |
| 2026-02-02 | 9.39x |
| 2026-01-30 | 9.08x |
| 2026-01-29 | 9.40x |
| 2026-01-28 | 9.25x |
| 2026-01-27 | 10.06x |
| 2026-01-26 | 10.09x |
| 2026-01-23 | 10.07x |
| 2026-01-22 | 10.05x |
| 2026-01-21 | 9.78x |
| 2026-01-20 | 8.86x |
| 2026-01-16 | 8.71x |
| 2026-01-15 | 8.76x |
| 2026-01-14 | 9.11x |
| 2026-01-13 | 8.81x |
| 2026-01-12 | 8.68x |
| 2026-01-09 | 8.52x |
| 2026-01-08 | 8.45x |
| 2026-01-07 | 8.40x |
| 2026-01-06 | 8.47x |
| 2026-01-05 | 8.75x |
| 2026-01-02 | 8.60x |
| 2025-12-31 | 8.59x |
| 2025-12-30 | 7.84x |
| 2025-12-29 | 8.98x |
| 2025-12-26 | 8.57x |
| 2025-12-24 | 8.32x |
| 2025-12-23 | 8.04x |
| 2025-12-22 | 8.20x |
| 2025-12-19 | 8.38x |
| 2025-12-18 | 8.27x |
| 2025-12-17 | 8.31x |
| 2025-12-16 | 8.17x |
| 2025-12-15 | 8.47x |
| 2025-12-12 | 8.36x |
| 2025-12-11 | 8.37x |
| 2025-12-10 | 8.41x |
| 2025-12-09 | 8.91x |
| 2025-12-08 | 8.10x |
| 2025-12-05 | 8.13x |
| 2025-12-04 | 7.57x |
| 2025-12-03 | 7.16x |
